Advertisement

Index by author

January 01, 2014; Volume 66,Issue 1

  1. Anagnostaras, Stephan G.

    1. Psychostimulants and Cognition: A Continuum of Behavioral and Cognitive Activation
      Suzanne Wood, Jennifer R. Sage, Tristan Shuman and Stephan G. Anagnostaras
      David R. Sibley, ASSOCIATE EDITOR, Department of Psychology, Columbia University, New York, New York (S.W.); and Molecular Cognition Laboratory, Department of Psychology (J.R.S., T.S., S.G.A.) and Program in Neurosciences (S.G.A.), University of California, San Diego, California
      Pharmacological Reviews January 2014, 66 (1) 193-221; DOI: https://doi.org/10.1124/pr.112.007054

  2. Bachelerie, Francoise

    1. International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors
      Francoise Bachelerie, Adit Ben-Baruch, Amanda M. Burkhardt, Christophe Combadiere, Joshua M. Farber, Gerard J. Graham, Richard Horuk, Alexander Hovard Sparre-Ulrich, Massimo Locati, Andrew D. Luster, Alberto Mantovani, Kouji Matsushima, Philip M. Murphy, Robert Nibbs, Hisayuki Nomiyama, Christine A. Power, Amanda E. I. Proudfoot, Mette M. Rosenkilde, Antal Rot, Silvano Sozzani, Marcus Thelen, Osamu Yoshie and Albert Zlotnik
      Eliot H. Ohlstein, ASSOCIATE EDITOR, INSERM UMR_S996, Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT), Université Paris-Sud, Clamart, France (F.B.); Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel (A.B.-B.); Department of Physiology and Biophysics, University of California Irvine, Irvine, California (A.M.B., A.Z.); INSERM UMR-S 945, Laboratoire d'Immunologie Cellulaire, Faculte de Medicine Pitie-Salpetriere, Paris, France (C.C.); Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (J.M.F., P.M.M.); Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow Biomedical Research Centre, Glasgow, United Kingdom (G.J.G., R.N.); Department of Pharmacology, University of California at Davis, Davis, California (R.H.); Laboratory for Molecular Pharmacology, Department of Neuroscience and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (A.H.S.-U., M.M.R.); University of Milan, Milan, Italy, and Humanitas Clinical and Research Institute, Rozzano, Italy (M.L., A.M.); Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (A.D.L.); Department of Molecular Preventive Medicine, School of Medicine, University of Tokyo, Tokyo, Japan (K.M.); Department of Molecular Enzymology, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan (H.N.); Geneva Research Centre, Merck Serono S. A., Geneva, Switzerland (C.A.P.); NovImmune SA, Geneva, Switzerland (A.E.I.P.); Medical Research Council Centre for Immune Regulation, Institute of Biomedical Research, School of Infection and Immunity, University of Birmingham, Birmingham, United Kingdom (A.R.); Department of Molecular and Translational Medicine, University of Brescia, Brescia, and Humanitas Clinical and Research Center, Rozzano, Italy (S.S.); Institute for Research in Biomedicine, Bellinzona, Switzerland (M.T.); and Department of Microbiology, Kinki University Faculty of Medicine, Osaka, Japan (O.Y.)
      Pharmacological Reviews January 2014, 66 (1) 1-79; DOI: https://doi.org/10.1124/pr.113.007724

  3. Baker, Anthony J.

    1. Cardiac Alpha1-Adrenergic Receptors: Novel Aspects of Expression, Signaling Mechanisms, Physiologic Function, and Clinical Importance
      Timothy D. O’Connell, Brian C. Jensen, Anthony J. Baker and Paul C. Simpson
      Paul A. Insel, ASSOCIATE EDITOR, Department of Integrative Biology and Physiology, University of Minnesota, Minneapolis, Minnesota (T.D.O); Cardiology Division, University of North Carolina, Chapel Hill, North Carolina (B.C.J.); and Cardiology Division, VA Medical Center and Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California (A.J.B., P.C.S.)
      Pharmacological Reviews January 2014, 66 (1) 308-333; DOI: https://doi.org/10.1124/pr.112.007203

  4. Barker, Eric L.

    1. Computational Methods in Drug Discovery
      Gregory Sliwoski, Sandeepkumar Kothiwale, Jens Meiler and Edward W. Lowe
      Eric L. Barker, ASSOCIATE EDITOR, Meiler Laboratory, Center for Structure Biology, Vanderbilt University, Nashville, Tennessee
      Pharmacological Reviews January 2014, 66 (1) 334-395; DOI: https://doi.org/10.1124/pr.112.007336

  5. Ben-baruch, Adit

    1. International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors
      Francoise Bachelerie, Adit Ben-Baruch, Amanda M. Burkhardt, Christophe Combadiere, Joshua M. Farber, Gerard J. Graham, Richard Horuk, Alexander Hovard Sparre-Ulrich, Massimo Locati, Andrew D. Luster, Alberto Mantovani, Kouji Matsushima, Philip M. Murphy, Robert Nibbs, Hisayuki Nomiyama, Christine A. Power, Amanda E. I. Proudfoot, Mette M. Rosenkilde, Antal Rot, Silvano Sozzani, Marcus Thelen, Osamu Yoshie and Albert Zlotnik
      Eliot H. Ohlstein, ASSOCIATE EDITOR, INSERM UMR_S996, Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT), Université Paris-Sud, Clamart, France (F.B.); Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel (A.B.-B.); Department of Physiology and Biophysics, University of California Irvine, Irvine, California (A.M.B., A.Z.); INSERM UMR-S 945, Laboratoire d'Immunologie Cellulaire, Faculte de Medicine Pitie-Salpetriere, Paris, France (C.C.); Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (J.M.F., P.M.M.); Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow Biomedical Research Centre, Glasgow, United Kingdom (G.J.G., R.N.); Department of Pharmacology, University of California at Davis, Davis, California (R.H.); Laboratory for Molecular Pharmacology, Department of Neuroscience and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (A.H.S.-U., M.M.R.); University of Milan, Milan, Italy, and Humanitas Clinical and Research Institute, Rozzano, Italy (M.L., A.M.); Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (A.D.L.); Department of Molecular Preventive Medicine, School of Medicine, University of Tokyo, Tokyo, Japan (K.M.); Department of Molecular Enzymology, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan (H.N.); Geneva Research Centre, Merck Serono S. A., Geneva, Switzerland (C.A.P.); NovImmune SA, Geneva, Switzerland (A.E.I.P.); Medical Research Council Centre for Immune Regulation, Institute of Biomedical Research, School of Infection and Immunity, University of Birmingham, Birmingham, United Kingdom (A.R.); Department of Molecular and Translational Medicine, University of Brescia, Brescia, and Humanitas Clinical and Research Center, Rozzano, Italy (S.S.); Institute for Research in Biomedicine, Bellinzona, Switzerland (M.T.); and Department of Microbiology, Kinki University Faculty of Medicine, Osaka, Japan (O.Y.)
      Pharmacological Reviews January 2014, 66 (1) 1-79; DOI: https://doi.org/10.1124/pr.113.007724

  6. Broekgaarden, Mans

    1. The Molecular Basis for the Pharmacokinetics and Pharmacodynamics of Curcumin and Its Metabolites in Relation to Cancer
      Michal Heger, Rowan F. van Golen, Mans Broekgaarden and Martin C. Michel
      David R. Sibley, ASSOCIATE EDITOR, Department of Experimental Surgery, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands (M.H., R.F.v.G., M.B.); and Department of Pharmacology, Johannes Gutenberg University, Mainz, Germany (M.C.M.)
      Pharmacological Reviews January 2014, 66 (1) 222-307; DOI: https://doi.org/10.1124/pr.110.004044

  7. Burkhardt, Amanda M.

    1. International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors
      Francoise Bachelerie, Adit Ben-Baruch, Amanda M. Burkhardt, Christophe Combadiere, Joshua M. Farber, Gerard J. Graham, Richard Horuk, Alexander Hovard Sparre-Ulrich, Massimo Locati, Andrew D. Luster, Alberto Mantovani, Kouji Matsushima, Philip M. Murphy, Robert Nibbs, Hisayuki Nomiyama, Christine A. Power, Amanda E. I. Proudfoot, Mette M. Rosenkilde, Antal Rot, Silvano Sozzani, Marcus Thelen, Osamu Yoshie and Albert Zlotnik
      Eliot H. Ohlstein, ASSOCIATE EDITOR, INSERM UMR_S996, Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT), Université Paris-Sud, Clamart, France (F.B.); Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel (A.B.-B.); Department of Physiology and Biophysics, University of California Irvine, Irvine, California (A.M.B., A.Z.); INSERM UMR-S 945, Laboratoire d'Immunologie Cellulaire, Faculte de Medicine Pitie-Salpetriere, Paris, France (C.C.); Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (J.M.F., P.M.M.); Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow Biomedical Research Centre, Glasgow, United Kingdom (G.J.G., R.N.); Department of Pharmacology, University of California at Davis, Davis, California (R.H.); Laboratory for Molecular Pharmacology, Department of Neuroscience and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (A.H.S.-U., M.M.R.); University of Milan, Milan, Italy, and Humanitas Clinical and Research Institute, Rozzano, Italy (M.L., A.M.); Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (A.D.L.); Department of Molecular Preventive Medicine, School of Medicine, University of Tokyo, Tokyo, Japan (K.M.); Department of Molecular Enzymology, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan (H.N.); Geneva Research Centre, Merck Serono S. A., Geneva, Switzerland (C.A.P.); NovImmune SA, Geneva, Switzerland (A.E.I.P.); Medical Research Council Centre for Immune Regulation, Institute of Biomedical Research, School of Infection and Immunity, University of Birmingham, Birmingham, United Kingdom (A.R.); Department of Molecular and Translational Medicine, University of Brescia, Brescia, and Humanitas Clinical and Research Center, Rozzano, Italy (S.S.); Institute for Research in Biomedicine, Bellinzona, Switzerland (M.T.); and Department of Microbiology, Kinki University Faculty of Medicine, Osaka, Japan (O.Y.)
      Pharmacological Reviews January 2014, 66 (1) 1-79; DOI: https://doi.org/10.1124/pr.113.007724

  8. Burnstock, Geoffrey

    1. Purinergic Signaling and Blood Vessels in Health and Disease
      Geoffrey Burnstock and Vera Ralevic
      Dianne M. Perez, ASSOCIATE EDITOR, Autonomic Neuroscience Centre, University College Medical School, London, United Kingdom and Department of Pharmacology, The University of Melbourne, Australia (G.B.); and School of Biomedical Sciences, Queen's Medical Centre, Nottingham, United Kingdom (V.R.)
      Pharmacological Reviews January 2014, 66 (1) 102-192; DOI: https://doi.org/10.1124/pr.113.008029

  9. Combadiere, Christophe

    1. International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors
      Francoise Bachelerie, Adit Ben-Baruch, Amanda M. Burkhardt, Christophe Combadiere, Joshua M. Farber, Gerard J. Graham, Richard Horuk, Alexander Hovard Sparre-Ulrich, Massimo Locati, Andrew D. Luster, Alberto Mantovani, Kouji Matsushima, Philip M. Murphy, Robert Nibbs, Hisayuki Nomiyama, Christine A. Power, Amanda E. I. Proudfoot, Mette M. Rosenkilde, Antal Rot, Silvano Sozzani, Marcus Thelen, Osamu Yoshie and Albert Zlotnik
      Eliot H. Ohlstein, ASSOCIATE EDITOR, INSERM UMR_S996, Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT), Université Paris-Sud, Clamart, France (F.B.); Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel (A.B.-B.); Department of Physiology and Biophysics, University of California Irvine, Irvine, California (A.M.B., A.Z.); INSERM UMR-S 945, Laboratoire d'Immunologie Cellulaire, Faculte de Medicine Pitie-Salpetriere, Paris, France (C.C.); Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (J.M.F., P.M.M.); Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow Biomedical Research Centre, Glasgow, United Kingdom (G.J.G., R.N.); Department of Pharmacology, University of California at Davis, Davis, California (R.H.); Laboratory for Molecular Pharmacology, Department of Neuroscience and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (A.H.S.-U., M.M.R.); University of Milan, Milan, Italy, and Humanitas Clinical and Research Institute, Rozzano, Italy (M.L., A.M.); Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (A.D.L.); Department of Molecular Preventive Medicine, School of Medicine, University of Tokyo, Tokyo, Japan (K.M.); Department of Molecular Enzymology, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan (H.N.); Geneva Research Centre, Merck Serono S. A., Geneva, Switzerland (C.A.P.); NovImmune SA, Geneva, Switzerland (A.E.I.P.); Medical Research Council Centre for Immune Regulation, Institute of Biomedical Research, School of Infection and Immunity, University of Birmingham, Birmingham, United Kingdom (A.R.); Department of Molecular and Translational Medicine, University of Brescia, Brescia, and Humanitas Clinical and Research Center, Rozzano, Italy (S.S.); Institute for Research in Biomedicine, Bellinzona, Switzerland (M.T.); and Department of Microbiology, Kinki University Faculty of Medicine, Osaka, Japan (O.Y.)
      Pharmacological Reviews January 2014, 66 (1) 1-79; DOI: https://doi.org/10.1124/pr.113.007724

  10. Dantzer, R.

    1. Neuroinflammation and Comorbidity of Pain and Depression
      A. K. Walker, A. Kavelaars, C. J. Heijnen and R. Dantzer
      Lynette C. Daws, ASSOCIATE EDITOR, Department of Symptom Research, Laboratory of Neuroimmunology of Cancer-Related Symptoms, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
      Pharmacological Reviews January 2014, 66 (1) 80-101; DOI: https://doi.org/10.1124/pr.113.008144
« Previous (Pages : 1 2 3 4 5 6 ... 6) Next »
Back to top

In this issue

Advertisement